Quantitative evaluation of drug-drug interactions with MTX using human kidney slices
Human kidney slices were incubated with buffer containing [3H]MTX in the presence or absence of inhibitors, and Ki values were determined by nonlinear regression analysis (Fig. 3). Plasma unbound concentrations of the inhibitors (Iu) were calculated from the total plasma concentrations and unbound fractions.
Inhibitors | Clinical Concentration | Ki | R Value | |
---|---|---|---|---|
Total | Iu | |||
μM | ||||
Salicylate | 1100-2200a | 55-440 | 18.4 ± 8.6 | 0.040-0.25 |
Diclofenac | 3.6b | <0.018 | 26.6 ± 5.2 | 1.0 |
Indomethacin | 0.84-84a | 0.084-8.4 | 3.11 ± 1.58 | 0.27-0.97 |
Ketoprofen | 12a | 0.0096 | 1.85 ± 0.96 | 1.0 |
Naproxen | >217a | 0.651 | 14.3 ± 5.3 | 0.96 |
Phenylbutazone | 162-786a | 6.3-19.0 | 4.87 ± 1.4 | 0.20-0.44 |
Probenecid | 170a | 18.7 | 0.171 ± 0.8 | 0.009 |
Ciprofloxacin | 7.6c | 4.5 | >1000 | 1.0 |